OOIR: Observatory of International Research

Papers

(The median citation count of Human Psychopharmacology-Clinical and Experimental is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans	22
N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine	22
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression	18
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis	14
Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships	13
Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings	13
High‐dose Vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression	13
Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials	12
Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates	12
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatients	12
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults	12
Effect of crocin versus fluoxetine in treatment of mild to moderate obsessive‐compulsive disorder: A double blind randomized clinical trial	11
Ayahuasca may help to improve self‐compassion and self‐criticism capacities	11
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users	11
Childhood maltreatment and clinical response to mood stabilizers in patients with bipolar disorder	10
Inverse correlation between plasma 2‐arachidonoylglycerol levels and subjective severity of depression	10
Effects of Korean red ginseng on human gray matter volume and cognitive function: A voxel‐based morphometry study	9
Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea	8
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis	8
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological st	7
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users	7
Restless Legs Syndrome among patients receiving antipsychotic and antidepressant drugs	7
Melatonin and melatonin‐agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta‐analysis	7
Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first‐episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms	7
Correlation between pharmacokinetics and pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Selective Serotonin and Noradrenaline Reuptake Inhibitors and maternal and neonatal outcomes: R	6

Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder	6
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z‐hypnotic drugs	6
Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice	5
Duloxetine attenuates pain in association with downregulation of platelet serotonin transporter in patients with burning mouth syndrome and atypical odontalgia	5
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder	5
Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study	5
Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system	4
An explorative approach to understanding individual differences in driving performance and neurocognition in long‐term benzodiazepine users	4
The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers	4
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics	4
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder	3
Nx4 attenuated stress‐induced activity of the anterior cingulate cortex—A post‐hoc analysis of a randomized placebo‐controlled crossover trial	3
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant	3
Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits	3
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial	3
Could N‐acetylcysteine improve the safety of clozapine?	3
Can placebo or nocebo pills improve or impair cognition performance?	3
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐m	3
Dexamphetamine influences funneling illusion based on psychometric score	2
Efficacy and acceptability of adjunctive n‐acetylcysteine for psychotic disorders: Systematic review and meta‐analysis	2
A narrative review of the neuropharmacology of synthetic cathinones—Popular alternatives to classical drugs of abuse	2
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study	2
Experience and views of healthcare professionals towards people who use new psychoactive substances: Evidence from statutory, non‐statutory, and private mental health and addiction healthcare services	2
The use of antipsychotics in obsessive compulsive disorder	2
Stress, caffeine and psychosis‐like experiences—A double‐blind, placebo‐controlled experiment	2
Efficacy of tiapride in the treatment of psychiatric disorders: A systematic review	2
Valproate‐associated hair abnormalities: Pathophysiology and management strategies	2
Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder	2
Lithium in bipolar depression: A review of the evidence	2
Aroma of the essential oil of peppermint reduces aggressive driving behaviour in healthy adults	2
Is short‐term antidepressant treatment effective and safe in bipolar depression? Results from an observational multicenter study	2
Estradiol treatment in young postmenopausal women with self‐reported cognitive complaints: Effects on cholinergic‐mediated cognitive performance	2
A pilot study assessing the brain gauge as an indicator of cognitive recovery in alcohol dependence	2
Low‐dose ketamine infusion in treatment‐resistant double depression: Revisiting the adjunctive ketamine study of Taiwanese patients with treatment‐resistant depression	2
A reappraisal of acute doses of benzodiazepines as a model of anterograde amnesia	2
Comparison of naltrexone implant and oral buprenorphine‐naloxone in the treatment of opiate use disorder	2
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first‐episode drug‐naive schizophrenic patients	2
Medication management of antipsychotic treatment in schizophrenia—A narrative review	2
J Guy Edwards, FRCPsych, FRCP, FRCGP (Hon), DPM, HonMFPH, Founding Editor of Human Psychopharmacology	1
Acute caffeine intake in humans reduces post exercise performance in learning and memory	1
Efficacy and safety of hydroxyzine for sleep in adults: Systematic review	1
Obstacles to treatment retention in opioid use disorder: An international substance use disorder treatment worker survey	1
Renal effects of long‐term lithium therapy, revisited	1
Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample	1
The first patient to receive olanzapine: A recollection	1
	1
A diffusion tensor imaging study in schizophrenia patients with clozapine induced obsessive compulsive symptoms	1
Factors associated with the severity of delirium	1
Resting state functional connectivity in adolescent synthetic cannabinoid users with and without attention‐deficit/hyperactivity disorder	1
Association of serotonin transporter gene polymorphism with efficacy of the antidepressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders	1

The chemical induction of synaesthesia	1
Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta‐analysis	1
Can antidepressant use be associated with emotional blunting in a subset of patients with depression? A scoping review of available literature	1
5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous	1
Peripheral edema associated with antidepressant use: Systematic review of case reports	1
Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double‐blind randomized controlled PULSAR study)	1
Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta‐analysis	1
The antimuscarinic agent biperiden selectively impairs recognition of abstract figures without affecting the processing of non‐words	1
Reproductive health in an inpatient psychiatric unit: A retrospective chart review	1
Facilitated extinction of conditioned fear responses by delta 9‐tetrahyrdrocannabidol in humans: a pilot study	1
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology	1
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo‐controlled study	1